Truist Financial
HAE icon

Truist Financial’s Haemonetics HAE Stock Holding History

Truist Financial’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,603
Closed -$308K – 2663
2023
Q4 		$308K Sell
3,603
-147
-4% -$12.7K ﹤0.01% 2294
2023
Q3 		$336K Sell
3,750
-829
-18% -$74K ﹤0.01% 2161
2023
Q2 		$390K Sell
4,579
-1,146
-20% -$96.9K ﹤0.01% 2108
2023
Q1 		$474K Buy
+5,725
New +$463K ﹤0.01% 2015
2021
Q1 		– Sell
-1,836
Closed -$218K – 2679
2020
Q4 		$218K Buy
+1,836
New +$198K ﹤0.01% 2344

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Truist Financial's HAE Position: Q1 2024 in Review

Truist Financial sold out of Haemonetics (HAE) in Q1 2024, closing a stake of 3,603 shares — an estimated $308K sold.

Truist Financial first reported a position in HAE in Q4 2020 and held it in 5 quarters. The position peaked at $474K in Q1 2023. 298 funds tracked by Wall St. Rank hold HAE as of Q1 2024.

  • Truist Financial reported no remaining Haemonetics position as of Q1 2024 after selling out during the quarter.
  • Truist Financial sold 3,603 Haemonetics shares in Q1 2024, an estimated $308K.
  • Truist Financial first reported a position in Haemonetics in Q4 2020 and held it in 5 quarters.
  • Truist Financial's Haemonetics position peaked at $474K in Q1 2023.
  • 298 funds tracked by Wall St. Rank held Haemonetics as of Q1 2024.

Based on Truist Financial's 13F filing for Q1 2024, filed 13 May 2024.